Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): A randomized, double-blinded, placebo-controlled parallel multi-center trial

M. G. Fehlings, H. Nakashima, N. Nagoshi, D. S.L. Chow, R. G. Grossman, B. Kopjar

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): A randomized, double-blinded, placebo-controlled parallel multi-center trial'. Together they form a unique fingerprint.

Medicine & Life Sciences